Dateline City:
SUMMIT, N.J.
First Chewable Tablet Approved for Fleas and Ticks in Dogs Effective for 12 Weeks (8 Weeks for Rhipicephalus sanguineus Ticks)
SUMMIT, N.J.--(BUSINESS WIRE)--MSD Animal Health, known as Merck Animal Health in the United States and
Canada, announced today that following a positive opinion from the
Committee for Medicinal Products for Veterinary Use (CVMP), the European
Commission has granted marketing authorization for the veterinary
medicinal product BRAVECTO (fluralaner) chewable tablets for dogs
(112.5 mg, 250 mg, 500 mg, 1000 mg, 1400 mg).
Language:
English
Contact:
Media:MSD Animal HealthAmy Firsching, +1 908-473-6357orPam Eisele, +1 908-423-5042
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more